树突细胞为动脉样硬化的免疫向治疗
Zhaohui Li1, Yanyan Yang2, Jinbao Zong3
1Department of Vascular Surgery, the Affiliated Hospital of Qingdao University, Qingdao, 266400, China.
Acta pharmaceutica Sinica. B
|April 3, 2025
概括
树突细胞是动脉样硬化中的关键免疫细胞,影响炎症和免疫反应. 基于树突细胞的疗法,包括疫苗和纳米输送,显示出治疗这种慢性炎症疾病的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管研究研究心血管研究
- 炎症生物学 炎症生物学
背景情况:
- 动脉样硬化是一种由免疫和炎症过程驱动的慢性炎症性疾病.
- 树突细胞 (DCs) 是关键的抗原呈现细胞,参与启动免疫反应和维持平衡.
- DCs在健康的动脉中发现,并积聚在动脉样硬化斑块中,突出显示它们在疾病中的作用.
研究的目的:
- 审查树突细胞及其子集在调节动脉样硬化炎症中的功能和机制.
- 探索树突细胞中心免疫疗法在动脉样硬化治疗中的潜力.
- 讨论动脉样硬化的树突细胞免疫疗法的挑战和未来方向.
主要方法:
- 文献综述侧重于动脉样硬化中的树突细胞功能.
- 分析当前的免疫治疗策略和疫苗接种方案.
- 检查纳米技术药物输送平台与基于直流的疗法相结合.
主要成果:
- 树突细胞显著影响动脉样硬化斑块的免疫和炎症环境.
- DC子集在动脉样硬化的开始和进展中起着不同的作用.
- 基于直流的免疫疗法,包括疫苗和纳米输送系统,显示出治疗潜力.
结论:
- 树突细胞是动脉样硬化中免疫反应的关键调节者.
- 基于DC的免疫疗法为治疗动脉样硬化提供了一个有希望的途径.
- 进一步研究DC免疫疗法,结合先进的输送系统,有必要克服挑战并优化治疗结果.
相关概念视频
Tumor Immunotherapy
432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432
Cytotoxic T Cells-mediated Immune Response
798
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
798
Cell-mediated Immune Responses
66.4K
Overview
66.4K
T Cell Types and Functions
689
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
689
Cell-surface Signaling
51.3K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
51.3K
Inflammation
52.0K
Overview
52.0K


